BIOCARTIS GROUP (8XB): key financial figures for fiscal year 2023 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2023)
- €47.4M
- Net Income/Loss (FY2023)
- €18.4M
- Total Assets (FY2023)
- €1.0M
- Total Equity (FY2023)
- €721.0K
- Cash Flows from Operating Activities (FY2023)
- -€47.8M
Source: BIOCARTIS GROUP annual_report filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
